4864-01-1

Basic information

• Product Name: 2-Methoxy-5-(trifluoromethyl)benzoic acid
• Synonyms: 2-Methoxy-5-(trifluoromethyl)benzoic acid;2-Methoxy-5-(trifluoromethyl)benzoic acid 97%
• CAS NO: 4864-01-1
• Molecular Formula: C₉H₇F₃O₃
• Molecular Weight: 220.15
• Mol File: 4864-01-1.mol
• Article Data: 3

Chemical Properties

• Melting Point: 108-111°C
• Boiling Point: 285 ºC
• Flash Point: 126 ºC
• Appearance: /
• Density: 1.380
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.474
• Storage Temp.: Sealed in dry,Room Temperature
• Water Solubility: Insoluble in water.
• CAS DataBase Reference: 2-Methoxy-5-(trifluoromethyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Methoxy-5-(trifluoromethyl)benzoic acid(4864-01-1)
• EPA Substance Registry System: 2-Methoxy-5-(trifluoromethyl)benzoic acid(4864-01-1)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 4864-01-1(Hazardous Substances Data)

Usage

Uses

2-Methoxy-5-(trifluoromethyl)benzoic acid is used as an intermediate in synthetic chemistry.

InChI:InChI=1/C9H7F3O3/c1-15-7-3-2-5(9(10,11)12)4-6(7)8(13)14/h2-4H,1H3,(H,13,14)

Upstream product

• 328-87-0 2-chloro-5-(trifluoromethyl)benzonitrile 
• 124-38-9 carbon dioxide 
• 402-10-8 2-bromo-1-methoxy-4-(trifluoromethyl)benzene 
• 1068-55-9 isopropylmagnesium chloride 
• 402-45-9 4-hydroxybenzotrifluoride 
• 402-52-8 methyl 4-(trifluoromethyl)phenyl ether 

Downstream Products

• 64507-07-9 2-methoxy-5-trifluoromethylbenzoyl chloride 
• 1140918-36-0 N-[(2Z)-5-tert-butyl-3-[(2R)-tetrahydrofuran-2-ylmethyl]-1,3-oxazol-2(3H)-ylidene]-2-methoxy-5-(trifluoromethyl)benzamide 
• 1140918-23-5 N-(3-tert-butyl-1-((tetrahydro-2H-pyran-2-yl)methyl)-1H-pyrazol-5-yl)-2-methoxy-5-(trifluoromethyl)benzamide 
• 1268463-99-5 6-methoxy-2-methyl-3-(trifluoromethyl)benzoic acid 
• 1268464-00-1 phenyl 6-methoxy-2-methyl-3-(trifluoromethyl)benzoate 
• 1268464-01-2 phenyl 6-hydroxy-2-methyl-3-(trifluoromethyl)benzoate 
• 1268464-02-3 phenyl 6-(benzyloxy)-2-methyl-3-(trifluoromethyl)benzoate 
• 1268464-03-4 phenyl 6-(tert-butoxycarbonyloxy)-2-methyl-3-(trifluoromethyl)benzoate 
• 1268464-04-5 (4aS,11aR,12aS,13S)-3,7-bis(benzyloxy)-4a-(tert-butyldimethylsilyloxy)-13-(dimethylamino)-5-hydroxy-10-(trifluoromethyl)-11a,12,12a,13-tetrahydrotetraceno[2,3-d]isoxazole-4,6(4aH,11H)-dione 
• 79427-88-6 2-hydroxy-5-(trifluoromethyl)benzoic acid 
• 1285517-52-3 (4-fluorophenyl)methyl 2-{[(4-fluorophenyl)methyl]oxy}-5-(trifluoromethyl)benzoate 
• 1285517-55-6 2-{[(4-fluorophenyl)methyl]oxy}-5-(trifluoromethyl)benzoic acid 
• 1285515-71-0 2-{[(4-fluorophenyl)methyl]oxy}-N-3-pyridinyl-5-(trifluoromethyl)benzamide 
• 1285515-73-2 2-{[(4-fluorophenyl)methyl]oxy}-N-4-pyridazinyl-5-(trifluoromethyl)benzamide 

Relevant articles and documents

TETRACYCLINE COMPOUNDS

The present invention is directed to a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising th

Substituted benzoic acid hypolipemic agents

Polysubstituted benzoic acids, and their use in mammals as hypolipemic agents.